ISTH 2020 CONGRESS: CANCER-ASSOCIATED THROMBOSIS ABSTRACT OVERVIEW
The recent International Society on Thrombosis and Haemostasis (ISTH) Congress, held on 12–14 July 2020, as a virtual...
LATEST ARTICLES
PATIENTS’ EXPERIENCE OF LIVING WITH CANCER-ASSOCIATED THROMBOSIS: THE PELICAN PROJECT
The clinical issues and the main consequences of venous thromboembolism (VTE) in patients with cancer are nowadays well...
COVID-19 Hemostasis and Malignancy: the Bergamo Experience
The COVID-19 pandemic took one of its biggest tolls on Italy, and especially in the northern area, in Lombardy. In this...
The Art of Managing Cancer-Associated Thrombosis: Caravaggio and Beyond
Venous thromboembolism (VTE) is a frequent complication and the second leading cause of death in cancer patients....
Fundamental research in oncology and thrombosis – the Frontline experience
What is the physician perception and common practice in treatment of venous thromboembolism (VTE) in cancer patients?...
Toward the replacement of low-molecular-weight heparins with the novel direct oral anticoagulants for the treatment of cancer-associated thrombosis
Value and limitations of low-molecular-weight heparins Following the demonstration that vitamin K antagonists (VKA) are...